EP2805723
Kladribín meðferðaráform til meðhöndlunar á heila- og mænusiggi
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
20.12.2005EP published:
17.1.2018EP application number:
14001970.4
EP translation filed:
18.1.2018Grant published:
15.3.2018EPO information:
European Patent Register
Max expiry date:
19.12.2025Expiry date:
19.12.2023
Title:
Cladribine regimen for treating multiple sclerosis
Timeline
Today
20.12.2005EP application
17.1.2018EP Publication
18.1.2018Translation submitted
15.3.2018Registration published
19.12.2023Expires
Owner
Name:
Merck Serono SAAddress:
Centre Industriel, 1267, Coinsins, Vaud, CH
Inventor
Name:
De Luca, GiampieroAddress:
Conches/GE, CH
Name:
Ythier, ArnaudAddress:
Collex-Bossy Geneva, CH
Name:
Munafo, AlainAddress:
Gilly, CH
Name:
Lopez-Bresnahan, MariaAddress:
Lincoln, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
638669 PDate:
22.12.2004Country:
US
Number:
04106909Date:
22.12.2004Country:
EP
Supplementary protection
SPC number:
SPC230
Classification
Categories:
A61K 31/7076, A61K 38/21, A61K 9/20, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 6.11.2018
Expires: 19.12.2019
Payer: Árnason Faktor
Number: 15
Paid: 7.11.2019
Expires: 19.12.2020
Payer: Árnason Faktor
Number: 16
Paid: 6.11.2020
Expires: 19.12.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 8.11.2021
Expires: 19.12.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 9.11.2022
Expires: 19.12.2023
Payer: Árnason Faktor ehf.